Yüklüyor......
Clinical efficacy and safety of evolocumab for low-density lipoprotein cholesterol reduction
Multiple categories of medications have been developed to manage lipid profiles and reduce the risk of cardiovascular events in patients with heart disease. However, currently marketed medications have not solved the problems associated with preventing and treating cardiovascular diseases completely...
Kaydedildi:
| Yayımlandı: | Vasc Health Risk Manag |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4844254/ https://ncbi.nlm.nih.gov/pubmed/27143910 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S82387 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|